225 related articles for article (PubMed ID: 34108854)
1. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Guo X; Tang L; Huang Q; Tang X
Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
[No Abstract] [Full Text] [Related]
2. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
3. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
J Neurol; 2024 May; ():. PubMed ID: 38771386
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
6. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
7. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
8. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
9. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Martín-Aguilar L; Querol L
Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
[TBL] [Abstract][Full Text] [Related]
13. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
14. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
15. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
Illa I
J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
Broers MC; Wieske L; Erdag E; Gürlek C; Bunschoten C; van Doorn PA; Eftimov F; Kuitwaard K; de Vries JM; de Wit MY; Nagtzaam MM; Franken SC; Zhu L; Paunovic M; de Wit M; Schreurs MW; Lleixà C; Martín-Aguilar L; Pascual-Goñi E; Querol L; Jacobs BC; Huizinga R; Titulaer MJ
J Neurol Neurosurg Psychiatry; 2023 Dec; 95(1):52-60. PubMed ID: 37879898
[TBL] [Abstract][Full Text] [Related]
17. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
Liberatore G; De Lorenzo A; Giannotta C; Manganelli F; Filosto M; Cosentino G; Cocito D; Briani C; Cortese A; Fazio R; Lauria G; Clerici AM; Rosso T; Marfia GA; Antonini G; Cavaletti G; Carpo M; Doneddu PE; Spina E; Cotti Piccinelli S; Peci E; Querol L; Nobile-Orazio E
Neurol Sci; 2022 Jun; 43(6):3939-3947. PubMed ID: 35048233
[TBL] [Abstract][Full Text] [Related]
18. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.
Yang MG; Xu L; Ji S; Gao H; Zhang Q; Bu B
Neuropsychiatr Dis Treat; 2022; 18():1207-1217. PubMed ID: 35734550
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
